Product Information
BUDESONIDE 2 MG RECTAL FOAM is a generic product labeled by Padagis Israel Pharmaceuticals Ltd, priced at $9.3483 per GM under NDC 45802062786. Its NADAC has been published 115 times since Apr 17, 2024.
Strength
2 mg/1
Manufacturer
Padagis Israel Pharmaceuticals LtdNDC
45802062786
Classification
Generic
Dosage Form
AEROSOL, FOAM
Route
RECTAL
Last Updated
6/17/2026
Active Ingredients
BUDESONIDEApproval Type
Generic (ANDA)
FDA Application
ANDA215328On Market Since
4/17/2023
Pharmacological Classes
Price Statistics
The NADAC for BUDESONIDE 2 MG RECTAL FOAM has been published 115 times since Apr 17, 2024, and over the history we have for it it has risen 13.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.3483 per GM |
|---|---|
| All-time high | $9.4874 (Mar 11, 2026) |
| All-time low | $7.0795 (Aug 21, 2024) |
| 52-week high | $9.4874 |
| 52-week low | $9.2330 |
| Median price | $9.2370 |
| Average price | $8.7852 |
| Largest weekly change | +6.7% (Oct 23, 2024) |
| Weeks tracked | 115 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 2 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 2 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of BUDESONIDE 2 MG RECTAL FOAM?
The current National Average Drug Acquisition Cost (NADAC) for BUDESONIDE 2 MG RECTAL FOAM, manufactured by Padagis Israel Pharmaceuticals Ltd, is $9.3483 per GM (NDC 45802062786), effective Jun 24, 2026.
How has the price of BUDESONIDE 2 MG RECTAL FOAM changed over time?
Over the history we have for it, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has risen 13.2%. It has been tracked across 115 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for BUDESONIDE 2 MG RECTAL FOAM?
Since Apr 17, 2024, the NADAC for BUDESONIDE 2 MG RECTAL FOAM has ranged from a low of $7.0795 (Aug 21, 2024) to a high of $9.4874 (Mar 11, 2026), with a median of $9.2370 per GM.
Are there cheaper alternatives to BUDESONIDE 2 MG RECTAL FOAM?
2 NADAC-published products share the same active ingredient, strength, and dosage form as BUDESONIDE 2 MG RECTAL FOAM, but none are currently priced below it.
Who manufactures BUDESONIDE 2 MG RECTAL FOAM?
BUDESONIDE 2 MG RECTAL FOAM (NDC 45802062786) is labeled by Padagis Israel Pharmaceuticals Ltd, and CMS classifies it as a generic product.
Related Drugs
Same classification